1H-NMR metabonomics analysis of sera differentiates between mammary tumor-bearing mice and healthy controls

Metabolomics

Volumn 1, Issue 3, 2005, Pages 269-278

  Whitehead, Tracy L ^a   Monzavi Karbassi, Behjatolah ^b   Kieber Emmons, Thomas ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

1H NMR spectroscopy; Breast cancer; Metabonomics

Indexed keywords

EID: 33644990748     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-005-0006-y     Document Type: Article

References (35)

1. Beckonert O., Monnerjahn J., Bonk U. and Leibfritz D. (2003) Visualizing metabolic changes in breast-cancer tissue using 1 H-NMR spectroscopy and self-organizing maps. NMR Biomed. 16, 1-11
2. Brindle J.T., Antti H., Holmes E., Tranter G., Nicholson J.K., Bethell H.W.L., Clarke S., Schofield P.M., McKilligin E., Mosedale D.E. and Grainger D.J. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1 H-NMR-based metabonomics. Nat. Med. 8, 1439-1444
3. Brindle J.T., Nicholson J.K., Schofield P.M., Grainger D.J. and Holmes E. (2003) Application of chemometrics to 1 H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 128, 32-36
4. Carlier P.G., Vaesen F., Gilles R.G., Fradin E.A. and Rorive G.L. (1991) Effect of oral contraception on water-suppressed proton NMR spectra of plasma. Magn. Reson. Med. 17, 269-273
5. Chmurny G.N., Hilton B.D., Halverson D., McGregor G.N., Klose J., Issaq H.J., Muschik G.M., Urba W.J., Mellini M.L., Costello R., Papadopoulos N.M., Caporaso N., et al. (1988) An NMR blood test for cancer: A critical assessment. NMR Biomed. 1, 136-150
6. de Graaf R.A., Behar K.L. (2003) Quantitative 1 H NMR Spectroscopy of Blood Plasma Metabolites. Anal. Chem. 75, 2100-2104
7. Eriksson L., Johansson E., Kettaneh-Wold N. and Wold S. (1999) Introduction to multi- and megavariate data analysis using projection methods (PCA & PLS). Umetrics, Umea, Sweden
8. Fossel E.T., Carr J.M. and McDonagh J. (1986) Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N. Engl. J. Med. 315, 1369-1376
9. Gadenholt G., Kruse S., Halsteinslid L., Sletten, E. (1990) Proton nuclear magnetic resonance spectroscopy of serum lipoproteins in rabbits with implanted VX-2 carcinoma. Eur. J. Cancer 26, 611-615
10. Goldsmith M.F. (1999) Leading sites of new cancer cases and deaths - 1999 estimates [letter]. JAMA 281, 405
11. Greenlee R.T., Murray T., Bolden S. and Wingo P.A. (2000) Cancer statistics, 2000. CA Cancer J. Clin. 50, 7-33
12. Gribbestad I.S., Sitter B., Lundgren S., Krane J. and Axelson D. (1993) Metabolite Composition in Breast Tumors Examined by Proton Nuclear Magnetic Resonance Spectroscopy. Anticancer Res. 19, 1737-1746
13. Hiraide H., Okamura S., Hiyashi T., Nishida M., Tamaki K. and Tamakuma S. (1994) The Urinary Excretion of Pyridinium Cross-links as Markers of Bone Metastasis in Breast Cancer. Breast Cancer 1, 103-108
14. Holmes E. and Antti H. (2002) Chemometric contributions to the evolution of metabonomics: Mathematical solutions to characterizing and interpreting complex biological NMR spectra. Analyst 127, 1549-1557
15. Holmes K.T., MacKinnon W.B., May G.L., Wright L.C., Dyne M., Tattersall M.H., Mountford C.E. and Sullivan D. (1988) Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer. NMR Biomed. 1, 44-49
16. Holmes E., Nicholls A.W., Lindon J.C., Ramos S., Spraul M., Neidig P., Connor S.C., Connelly J., Damment S.J., Haselden J. and Nicholson J.K. (1998) Development of a model for classification of toxin-induced lesions using 1 H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 11, 235-244
17. Holmes E., Nicholls A.W., Lindon J.C., Connor S.C., Connelly J.C., Haselden J.N., Damment S.J., Spraul M., Neidig P. and Nicholson J.K. (2000) Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol. 13, 471-478
18. Lasker S.E., Iatropoulos M.J., Hecht S.S., Misra B., Amin S., Zang E. and Williams G.M. (1992) N-ethyl-N-nitrosourea induced brain tumors in rats monitored by nuclear magnetic resonance imaging, plasma protein nuclear magnetic resonance spectroscopy and microscopy. Cancer Lett. 67, 125-131
19. Leray G. and de Certaines J.D. (1994) Proton NMR spectroscopy of plasma lipoproteins: A marker of the immune function in cancer disease? Anticancer Res. 14, 1839-1851
20. Lindon J.C., Nicholson J.K. and Everett J.R. (1999) NMR spectroscopy of biofluids. Annu. Rep. NMR Spectrosc. 38, 1-88
21. Lindon J.C., Nicholson J.K., Holmes E. and Everett J.R. (2000) Metabonomics: Metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn. Reson. 12, 289-320
22. Monzavi-Karbassi, B., Whitehead, T.L., Jousheghany, F. et al. (2005). Deficiency in Sialyl Lewis X Oligosaccharides promote metastasis in a mouse model of breast cancer. Int. J. Cancer 117, 398-408
23. Nicholson J.K., Wilson I.D. (1989) High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. NMR Spectroscop. 21, 444-501
24. 13C NMR Spectroscopy of Human Blood Plasma. Anal. Chem. 67, 793-811
25. Nicholson J.K., Lindon J.C. and Holmes E. (1999) "Metabonomics": Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189
26. Nicholson J.K., Connelly J., Lindon J.C. and Holmes E. (2002) Metabonomics: A platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153-161
27. Odunsi K., Wollman R.M., Ambrosone C.B., Hutson A., McCann S.E., Tammela J., Geisler J.P., Miller G., Sellers T., Cliby W., Qian F., Keitz B., Intengan M., Lele S. and Alderfer J.L. (2005) Detection of epithelial ovarian cancer using 1 H-NMR-based metabonomics. Int. J. Cancer 113, 782-788
28. Okunieff P., Zietman A., Kahn J., Singer S., Neuringer L.J., Levine R.A., Evans F.E. (1990) Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors. N. Engl. J. Med. 322, 953-958
29. Pawlik T.M., Fritsche H., Coombes K.R., Xiao L, Krishnamurthy S., Hunt K.K., Pusztai L., Chen J.N., Clarke C.H., Arun B., Hung M.C. and Kuerer H.M. (2005) Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res. Treat. 89, 149-157
30. Piotto M., Saudek V. and Sklenar V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661-665
31. Schalk K.P., Ruterjans H., Kaltwasser J.P., Said-l-Hadj H. and Staffenberger L. (1989) Tumor detection in serum by NMR spectrometry. A critical evaluation of the so-called Fossel test. Onkologie 12, 5-8
32. Tang H., Wang Y., Nicholson J.K. and Lindon J.C. (2004) Use of relaxation-edited one-dimensional and two-dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal. Biochem. 325, 260-272
33. Verdery R.B., Benham D.F., McLennan I., Busby M.J., Wehrle J.E. and Glickson J.D. (1989) Proton nuclear magnetic resonance methyl and methylene linewidths from plasma decrease during postprandial lipemia. Biochim. Biophys. Acta 1006, 287-290
34. Whitehead T.L., Monzavi-Karbassi B., Jousheghany F., Artaud C., Elbein A., Kieber-Emmons T. (2005) 1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model, Int. J. Oncol. 27, 257-264
35. Wold S., Antti H., Lindgren F. and Ohman J. (1998) Orthogonal signal correction of near-infrared spectra. Chemom. Intell. Lab. Syst. 44, 175-185